Exploration of In Vivo T-cell Depletion protocols in Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies
{{output}}
Graft-versus-host disease (GVHD) remains a major concern following allogeneic hematopoietic stem cell transplantation (allo-HSCT). Two principal in vivo T-cell depletion (TCD) strategies-post-transplant cyclophosphamide (PTCY)-based and anti-thymocyte globulin... ...
